Appropriateness of non-vitamin K antagonist oral anticoagulant dose in patients with atrial fibrillation in Israel: A population-based study

被引：6
作者：
Ellis, Martin H. [1 ,2 ,3 ]
Dotan, Sari Greenberg [4 ]
Hammerman, Ariel [4 ]
Battat, Erez [4 ]
Derazne, Estela [3 ]
Avnery, Orly [1 ,2 ,3 ]
机构：
[1] Meir Med Ctr, Inst Hematol, Kefar Sava, Israel
[2] Meir Med Ctr, Blood Bank, Kefar Sava, Israel
[3] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[4] Clalit Hlth Serv, Tel Aviv, Israel
来源：
THROMBOSIS RESEARCH | 2018年 / 169卷
关键词：
NOAC dose; Atrial fibrillation; Population study; STROKE PREVENTION; NATIONWIDE COHORT; DABIGATRAN; WARFARIN; RIVAROXABAN;
D O I：
10.1016/j.thromres.2018.07.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：140 / 142
页数：3
相关论文
共 10 条
[1]  
[Anonymous], EUR SOC CARD C
[2]   Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study [J].
Ellis, Martin H. ;
Neuman, Tsipora ;
Bitterman, Haim ;
Dotan, Sari Greenberg ;
Hammerman, Ariel ;
Battat, Erez ;
Eikelboom, John W. ;
Ginsberg, Jeffrey S. ;
Hirsh, Jack .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 33 :55-59
[3]   Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation [J].
Graham, David J. ;
Reichman, Marsha E. ;
Wernecke, Michael ;
Zhang, Rongmei ;
Southworth, Mary Ross ;
Levenson, Mark ;
Sheu, Ting-Chang ;
Mott, Katrina ;
Goulding, Margie R. ;
Houstoun, Monika ;
MaCurdy, Thomas E. ;
Worrall, Chris ;
Kelman, Jeffrey A. .
CIRCULATION, 2015, 131 (02) :157-164
[4]   Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation [J].
Lane, Deirdre A. ;
Lip, Gregory Y. H. .
THROMBOSIS AND HAEMOSTASIS, 2014, 111 (03) :381-383
[5]   Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation [J].
Marzec, Lucas N. ;
Wang, Jingyan ;
Shah, Nilay D. ;
Chan, Paul S. ;
Ting, Henry H. ;
Gosch, Kensey L. ;
Hsu, Jonathan C. ;
Maddox, Thomas M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (20) :2475-2484
[6]   Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study [J].
Nielsen, Peter Bronnum ;
Skjoth, Flemming ;
Sogaard, Mette ;
Kjaeldgaard, Jette Nordstrom ;
Lip, Gregory Y. H. ;
Larsen, Torben Bjerregaard .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
[7]   Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation [J].
Potpara, Tatjana S. ;
Lip, Gregory Y. H. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (11) :1115-1116
[8]   Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study [J].
Staerk, L. ;
Gerds, T. A. ;
Lip, G. Y. H. ;
Ozenne, B. ;
Bonde, A. N. ;
Lamberts, M. ;
Fosbol, E. L. ;
Torp-Pedersen, C. ;
Gislason, G. H. ;
Olesen, J. B. .
JOURNAL OF INTERNAL MEDICINE, 2018, 283 (01) :45-55
[9]   Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes The ORBIT-AF II Registry [J].
Steinberg, Benjamin A. ;
Shrader, Peter ;
Thomas, Laine ;
Ansell, Jack ;
Fonarow, Gregg C. ;
Gersh, Bernard J. ;
Kowey, Peter R. ;
Mahaffey, Kenneth W. ;
Naccarelli, Gerald ;
Reiffel, James ;
Singer, Daniel E. ;
Peterson, Eric D. ;
Piccini, Jonathan P. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (24) :2597-2604
[10]   Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation [J].
Yao, Xiaoxi ;
Abraham, Neena S. ;
Sangaralingham, Lindsey R. ;
Bellolio, M. Fernanda ;
McBane, Robert D. ;
Shah, Nilay D. ;
Noseworthy, Peter A. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06)
1